Technology: ELISA (Enzyme-Linked Immunosorbent Assay); intended for the qualitative detection of the human IgG antibodies
Specificity: 98%
Sensitivity: 97.5%
CE-IVD
This test kit is able to tell if you have already had in the past COVID-19, testing for IgG antibodies. IgG antibodies develop in the later stage of the infection and persist for a long time after recovery. Your results indicate both a recent infection and a past infection
This test can be used to find out which part of the population has already been infected and may be immune to COVID-19. Experience with other viruses suggests that individuals who have antibodies may be able to resume work and other daily activities in society
Our test is Laboratory-based (No Quick Test!). Take a few drops of blood from your fingertip and send the sample to us. The collection method is easy-to-use and painless
We ship you a collection kit to your home with clear instructions and a prepaid envelope
The test kit includes a CE-IVD Finger Prick Blood Collection Device. Collecting your blood sample takes just a few minutes. Then, register your kit on our website
Use the prepaid envelope to ship your kit back to us. The return shipping is overnight with premium courier shipping
Within 48 hours of your sample arriving at the lab, you will receive the test results. You will have unlimited access to our team for follow-up advice
Technology: ELISA (Enzyme-Linked Immunosorbent Assay); intended for the qualitative detection of the human IgG antibodies
Specificity: 98%
Sensitivity: 97.5%
CE-IVD
There are three outcomes possible from the testing.
- Positive - testing positive for the virus means that the sample provided contains SARS-CoV-2 viral RNA. This result could be returned even in the absence of symptoms.
- Negative - this result means that the sample provided does not contain detectable levels of SARS-CoV-2 viral RNA. However, you could have been previously infected by the virus and you could be infected at a future date.
- Inconclusive - this result means that the test results did not meet the requirements to be reported as a positive detection of SARS-CoV-2 viral RNA in the sample, and should be treated clinically as Not Detected. However, this also means that there was partial detection of a signal from SARS-CoV-2 that warrants notification under duty of care for further investigation. Re-testing in these cases is recommended.